-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Upgrades Qiagen to Overweight, Raises Price Target to $55

Benzinga·10/06/2026 12:11:28
Listen to the news
Barclays analyst Luke Sergott upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight and raises the price target from $40 to $55.